Capital Markets Day Presentation. November 2017

Size: px
Start display at page:

Download "Capital Markets Day Presentation. November 2017"

Transcription

1 Capital Markets Day Presentation November 2017

2 Disclaimer This information contained in the Capital Markets Day Presentation has been prepared by NMC Health and was compiled from sources believed to be reliable for informational purposes only. Prospective and existing investors should make their own evaluation of the company as the information provided here does not purport to be all inclusive or to contain all of the information a prospective or existing investor may desire. In all cases, interested parties should conduct their own investigation and analysis of the Company and the date set forth in this information. NMC Health makes no representation or warranty as to the accuracy or completeness of this information and shall not have any liability for any representations (expressed or implied) regarding information contained in, or for any omissions from, this information or any other written or oral communications transmitted to the recipient in the course of its evaluation of the Company. This presentation may contain forward looking statements including statements regarding our intent, belief or current expectations with respect to NMC s businesses and operations. Such forward-looking information and statements reflect current views with respect to future events and are subject to risks, uncertainties and assumptions. The Company cannot give assurance to the correctness of such information and statements. Many actual events and circumstances are beyond the control of the Company. 2

3 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 3

4 Changing lives and impacting society positively 4

5 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 5

6 Institutionalizing the business Focus on maintaining operational excellence Drive organisation culture Oversee quality, safety and patient satisfaction Oversite of financial expectations through oversight of operations Oversight of healthcare operations Manage relationships with regulatory agencies Mitigate risks and potential barriers to success Physician relations 6

7 Philosophy and methodology Enhancing NMC s current leadership framework by introducing concepts acquired from extensive experience in the US and UAE Maintain NMC s strong Abu Dhabi legacy while introducing a more western approach to organizational structure and decision making Create a corporate leadership hierarchy that focuses on the five pillars needed for our long term success: Cost, quality, service, growth, and people New management structure introduced to decentralize decision making Operational clusters created within the UAE and broader Middle East to empower front line leadership to control their business The new structure eliminates hurdles to quick decision making at the ground level and streamlines operations Previously higher level decisions regarding HR, operations, and business development were elevated to the corporate leadership Committed to evaluation of existing operational leadership across all portfolios and making changes if necessary 7

8 New corporate structure CEO Prasanth Manghat COO-Healthcare Michael Davis COO-Distribution Nirman Shetty Head of IVF Prakash Janardan Director Corporate Services Ravi Rai CFO Prashant Shenoy CMO Dr. C R Shetty CIO Hani Buttikhi Dy. COO Distribution Head of Clinica Eugin Head of Fakih IVF Business development Regional Head Abu Dhabi and Al Ain Regional Head Dubai and Northern Emirates Head Outside of UAE Head of Operations Abu Dhabi, Al Ain and Dubai Head of Operations Sharjah, Oman, Kuwait and Qatar Head of Operations Saudi Arabia Head of Human Resources and Personnel Head of Marketing and Sales Head of Quality Head of Nursing Investor Relations Corporate Development Mergers and Acquisitions Dy. CFO accounts and audit Dy. CFO banking and treasury AVP corporate finance IT 8 Note: Brand strategy and communication strategy will report functionally to CEO

9 Substantial segment and geographic diversification MULTI-SPECIALITY NETWORK 01. NMC Specialty Hospital Abu Dhabi 02. NMC Day Surgery 1 Mohammed Bin Zayed City MATERNITY & FERTILITY 17. Brightpoint Royal Women's Hospital 1 Abu Dhabi (Opened 2014) 18. Clinica Eugin 2 Spain (Acquired 2015) 26. Emirates Healthcare Dubai 27. Sheikh Khalifa Hospital Yemen DISTRIBUTION 35. NMC Warehouse DIC, Dubai 36. NMC Warehouse Ajman Ajman 03. Dr. Sunny Referral Network Sharjah (Acquired 2015) 19. Fakih IVF UAE (Acquired 2015) 28. NMC Sales and Marketing Office Abu Dhabi 04. NMC Royal Hospital 1 Khalifa City (Opened 2015) 05. NMC General Hospital 1 Dubai Investments Park (Opened 2014) 06. B.R. Medical Suites DHCC 07. NMC General Hospital Deira, Dubai 08. NMC Specialty Hospital Dubai 09. NMC Medical Centre Sharjah 10. NMC Specialty Hospital AI Ain 11. NMC Medical Centre 1 Al Ain (Opened 2014) 12. American Surgecenter Abu Dhabi 13. Al Zahra Hospital Sharjah (Acquired 2016) 14. Atlas Healthcare Muscat, Oman (Acquired 2017) LONG-TERM & HOME CARE 20. Provita Abu Dhabi (Acquired 2015) 21. Provita Al Ain (Acquired 2015) 22. Americare Abu Dhabi (Acquired 2015) 23. As Salama Saudi Arabia (Acquired 2016) 24. Chronic Care Saudi Arabia (Acquired 2016) OPERATION & MANAGEMENT 25. Sheikh Khalifa General Hospital (Operator) Umm al Quwain SAUDI ARABIA 29. NMC Sales and Marketing Office AI Ain 30. NMC Sales and Marketing Office Dubai and Northern Emirates 31. NMC Warehouse Mina. Abu Dhabi 32. NMC Warehouse AI Ain 33. NMC Warehouse DIP, Dubai 34. NMC Warehouse Al Quoz, Dubai Umm Al Quwain Sharjah Dubai UNITED ARAB EMIRATES 15. Najran Hospital Saudi Arabia (Acquired 2017) 16. Ha il Hospital Saudi Arabia (Acquired 2017) 15 YEMEN Abu Dhabi Al Ain OMAN Funded from IPO proceeds 2. Also has operations in Italy, Denmark, Brazil and Columbia

10 Operational integration Gelling the new with the old Rapid pace of acquisitions necessitates a pro-active role to balance the differences in cultures across the various entities Distribution Multi-specialty network Corporate & local culture Operations & Management Long-term & Home Care Maternity & Fertility Leadership & strategic vision Dedicated in-country specialists Well positioned to manage growth across further geographies 10 10

11 Operational integration The next phase Continuing the next phase integration of newly acquired assets whilst becoming the employer of choice in the healthcare sector Integration of culture Rolling up newly acquired assets under broader leadership to complete integration of culture Source out further efficiency opportunities Examples: ProVita / Americare, Nadia Medical Centre/ Brightpoint Royal Back office rationalisation Consolidation and rationalisation of back office functions across the portfolio Examples: NMC Sharjah, Al Zahra Hospital and Dr. Sunny Healthcare & ProVita, Americare, Emirates National Home Health Employer of choice Focus on people & culture greater alignment with employee incentives (birthday leave and tickets home) Implementation of performance management system Top Companies to Work for in the UAE ProVita, Abu Dhabi & Al Ain Americare, Abu Dhabi Brightpoint Royal Woman s Hospital, Abu Dhabi Nadia Medical Centre, Abu Dhabi Al Zahra Hospital, Sharjah New Medical Centre, Sharjah Dr Sunny Healthcare, Sharjah 11 11

12 Operational integration Optimizing existing assets Cross referrals Lab, laundry and pharmacy centralisation Back office consolidation Sales and marketing Right size organisation CONTINUED FOCUS ON OPTIMIZATION Increasing accountability Firm negotiation of rates Minimization of insurance rejection rates a key focus area 12 12

13 Operational integration Identifying the right traits for acquisition Rigorous but efficient evaluation and execution process How do we assess potential assets in KSA? Targeting pole position in the Omani Market Alignment with strategic verticals in attractive market Cultural fit with existing leadership teams and shareholders Focus on providing solid clinical care or providing clinical services that are underserved within given geography Track record of operational efficiency with upside potential Underpenetrated market with strong demand drivers Rebranded NMC portfolio Clinically stable and profitable asset base from which to expand upon Navigating the Saudi market Knowledge and expertise gained by being on the ground Oman private healthcare sector market share Investment philosophy focused on opportunity and relative value 100 beds 20% market share Comprehensive due diligence 13 13

14 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 14 14

15 Getting pregnant is not that easy Variety of causes Ovulation problems 35% Others 45% Sperm production temporarily decreased Sperm obstruction 1 out of 6 every attempts results in pregnancy Blockage of Fallopian Tubes 15% 33% Endometriosis 5% Unknown causes 14% Low sperm count External causes 20% 33% Low mobility Malformed sperm with options decreasing over time 86% 78% 63% 52% 36% 0% 5% AGE 15 15

16 NMC Fertility: A globally leading, premium provider of fertility treatment NMC Fertility is the second largest player in fertility treatments globally and has a network of clinics to access patients across 3 continents 7 clinics in Europe 4 clinics in GCC 5 clinics in LatAm Full range of fertility treatments Specialized in Sharia-compliant treatment Covering a wide range of patients and offering donor cycles NMC Fertility platform has a differentiated positioning adapted to each of its markets Competitive pricing combined with medical excellence and scientific rigor with Eugin in Europe Mid-to-high end positioning in LatAm combining local doctors reputation and Eugin/Huntington brands High-end positioning for a premium clientele with Fakih in the GCC 16 16

17 A global fertility platform with leading presence in core markets Fakih Dubai Fakih No. of clinics: 1 Fakih Abu Dhabi Fakih No. of clinics¹: 2 Eugin Spain Eugin No. of clinics: 2 CIRH Eugin No. of clinics: 1 Eugin Italy Eugin No. of clinics: 3 CFC Denmark Eugin No. of clinics: 1 Eugin Colombia Eugin No. of clinics: 1 Huntington Eugin No. of clinics: 4 Current Eugin s presence Current Fakih s presence Key markets Ranking #2 #1 #1 #1 #1 Market share (by # of cycles) NMC Fertility 8% 6% 11% 36% 7% Combined top 3 players 42% 11% 28% 56% 18% Source: NMC Health estimates 17 17

18 Significant opportunity for a global leader to consolidate the fast growing fertility treatment market Top 5 players account for only c.5% global market share in a fast growing market projected at c.us$21bn by 2020 Combined top 5 players market share by number of cycles (2016): Global fertility services market (US$bn) 1 : EMEA Americas APAC 20.8 CAGR 2.6m IVF cycles globally 5% % +8.1% % 2015A 2020E Source: Technavio Global Fertility Service Market Market sizes cover the global fertility services market (including infertility drugs and services in Assisted Reproductive Technology) 18 18

19 Multi-dimensional platform well positioned for further expansion Development of pan-continental presence across the Middle East, Europe and the Americas provides scale and flexibility to drive quality, access to treatments and innovation Patient referrals and transfers within the Group Comprehensive range of fertility treatments Expertise in opening and integrating new clinics Global R&D collaborations and network Deep knowledge of all regulatory frameworks Our patients can choose to receive treatment at any facility in any country Egg, sperm and embryo movement between the clinics Transforming Europe s largest egg donation program into a global program with diversity of phenotypes Offering shariacompliant services in relevant markets Successful integration of acquisitions Track record of organic openings R&D collaborations with over 15 institutions Medical committees of renowned IVF practitioners and scientific leaders Ability to optimize use of legislations and provide innovative solutions to patients Cross-border embryo transfer 19 19

20 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 20 20

21 Verticals of operations Pharma One of UAEs largest teams of medical & sales reps Visiting over 30,000 licensed doctors in UAE monthly Selling to all 1,500 pharmacies, 150 hospitals and >1,000 medical centers and clinics Medical Equipment, Consumables and Devices Solutions to the healthcare industry including Primary, Surgical, Specialty &Critical Care, Laboratory and Radio diagnostics, Medical Furniture and Rehabilitation Selling to all 1,500 pharmacies, 150 hospitals and >1,000 medical centers and clinics Veterinary Providing feed, care, grooming and medical solutions to stables, dairies, poultries, vet clinics and hospitals Consumer Education One of UAEs largest FMCG products distributor across personal care, food, beverages, household care and home improvement >7,000 points of sale across supermarkets, groceries, gas stations, hotels, cafes, wholesalers Solutions for schools including furniture, sports equipment, study aids, lab & ICT equipment 21 21

22 NMC Trading overview Sales One of the largest sales forces with a single company in the UAE Sales team of >750 professionals Value added services to establish and grow brands in the UAE market Over 10,000 customers (1,000 clinics, medical centers & hospitals, 30,000 doctors, 1500 pharmacies, 500 schools, >7,000 supermarkets, groceries, gas stations Technical Service Wide range of premier medical equipment services Authorised Service Provider (ASP) certification from multiple partners Two Specialised Biomedical Engineering Workshops with certified safety, testing and calibration analysers Marketing Focus on below the line marketing activities Typically happen at points of sale & at consumer hubs Methods include: maximizing visibility & share of shelf at point of sale, new brand launches and offer packs, retail event calendar participation Merchandizing With >400 people, one of UAEs largest teams of merchandisers Key methods include availability and visibility of products on shelf, execution of planograms, POS communications, minimize stock returns Promotions Build brand awareness by educating customers Undertake trials via dry and wet sampling for food products, organizing special promotional events such as screening camps within companies Regulatory Strong regulatory team for each vertical taking care of all compliance issues Helps partners comply with the respective regulator - municipalities, ministries & chambers of commerce Warehousing >500,000 sq ft of warehousing across the UAE Capacity of over 40,000 pallets Multiple temperature ranges including cold chain State of the art put away and pick systems minimize turnaround times and reduces error rates Analytics Investment in analytic capabilities allowing faster insights than competitors Key areas include customer channel penetration, value and order frequency, SKU product analysis, return on marketing investments, customer service reports Delivery 48-hour order to delivery commitment for all verticals Delivers >2,000 orders a day Over 250 delivery vehicles all GPS enabled allowing realtime tracking, status of delivery targets and vehicle status 22

23 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 23 23

FY 2014 Results Presentation. 24 February, 2015

FY 2014 Results Presentation. 24 February, 2015 FY 2014 Results Presentation 24 February, 2015 Senior management presenting Prasanth Manghat Deputy CEO Roy Cherry Head of Strategy & IR Suresh Krishnamoorthy CFO 2 Contents 1. FY 2014 highlights 2. Financial

More information

For personal use only

For personal use only Virtus Health (ASX. VRT) Sue Channon CEO and Glenn Powers CFO Navigating Future Growth, UBS Australasian Conference 7 November, 2016 DISCLAIMER 2 The material in this presentation has been prepared by

More information

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018 ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates

More information

The Dental Corporation Opportunity

The Dental Corporation Opportunity The Dental Corporation Opportunity for Practice Principals. It s the perfect professional collaboration. You focus on dentistry, we look after the paperwork. In recognition of what you, the Practice Principal,

More information

An exciting combination in a high growth, high margin Nutrition category. Name of chairman

An exciting combination in a high growth, high margin Nutrition category. Name of chairman An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views

More information

Investor Presentation

Investor Presentation ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an

More information

For personal use only

For personal use only ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting

More information

January 30, 2018 Dow Wilson President and Chief Executive Officer

January 30, 2018 Dow Wilson President and Chief Executive Officer Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking

More information

Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer,

Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer, Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer, Workstation), Technology (AI, Gamete Donation, IVF, ICSI,

More information

For personal use only. Investor Briefing. Bayswater, 1 st December 2016

For personal use only. Investor Briefing. Bayswater, 1 st December 2016 Investor Briefing Bayswater, 1 st December 2016 Introduction Samantha Cheetham Chief Executive Officer To be an innovative leader in the dental industry, developing our people and partnering with dentists

More information

KAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO

KAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO KAPITALMARKNADSDAG 20 SEPTEMBER 2016 Thomas Axelsson, CEO 1 AGENDA 16.10-16.30 VD har ordet Thomas Axelsson, CEO 16.30-16.50 Clinical relevance of time-lapse Dr. Niels B. Ramsing, Business Unit Time-lapse,

More information

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( )

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( ) Global Invisible Braces Market: Trends, Opportunities and Forecasts (2016-2021) By Types Clear Aligners, Ceramic, Lingual By Region Americas, Europe, Middle East, Africa, Asia-Pacific By Country- USA,

More information

Shareholder Presentation Annual Meeting 2018

Shareholder Presentation Annual Meeting 2018 Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)

More information

Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS

Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s

More information

Delivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental

Delivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental Delivering Results POSITIONED FOR GROWTH Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental PAUL GUGGENHEIM CEO, Patterson Dental Former owner and president, Guggenheim Brothers

More information

DUBAI SEIZES HALAL INITIATIVE. Farrelly & Mitchell Executive Report

DUBAI SEIZES HALAL INITIATIVE. Farrelly & Mitchell Executive Report DUBAI SEIZES HALAL INITIATIVE Executive Report October, 2015 Food, Beverage & Agribusiness: Commercial & Technical Due Diligence Eng. Najeeb Alhumaid Regional Manager, Middle East & Africa E: nalhumaid@farrellymitchell.com

More information

ABOUT. CIEL Healthcare Limited ( CHL ), a subsidiary of CIEL Limited, is a Mauritian registered private limited

ABOUT. CIEL Healthcare Limited ( CHL ), a subsidiary of CIEL Limited, is a Mauritian registered private limited FACTSHEET ABOUT CIEL Healthcare Limited ( CHL ), a subsidiary of CIEL Limited, is a Mauritian registered private limited company, with a prime objective to own, operate and manage assets in the healthcare

More information

STRATEGIC PLAN

STRATEGIC PLAN STRATEGIC PLAN 2019-2028 3 EXECUTIVE SUMMARY Health at the center Good health changes everything. With good health, children can learn, parents can provide and neighbors can work together to build, and

More information

Wednesday 26 th November 2008 The ASX Company Announcements office: Chairman s AGM Address

Wednesday 26 th November 2008 The ASX Company Announcements office: Chairman s AGM Address Advanced Molecular Diagnostic Systems The Walter and Eliza Hall Biotechnology Centre, 4 Research Avenue, La Trobe R&D Park, Bundoora, Victoria 3083 T: +61 (0)3 9345 2127 F: +61 (0)3 9345 2242 Wednesday

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We

More information

Investment in MGC Pharmaceuticals

Investment in MGC Pharmaceuticals Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information

More information

STRATEGIC PLAN

STRATEGIC PLAN 2019-2022 STRATEGIC PLAN Thank you for your interest in our work! On behalf of The Friends staff and board of directors, we are excited to share our 2019-2022 Strategic Plan with you. This document represents

More information

Welcome to Galenicum! APRIL, 2013

Welcome to Galenicum! APRIL, 2013 Welcome to Galenicum! APRIL, 2013 Our corporate image comes from the sunrise. Night represents disease, daylight means health and the sunrise stands for overcoming GALENICUM CORPORATE PRESENTATION 3 Who

More information

Country Coverage. Company Coverage

Country Coverage. Company Coverage Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon

More information

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( ) Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications

More information

Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America

Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America Media release Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America Group net revenue rises 2% (l.c.) as double-digit increases across America offset

More information

Committed to Environment, Health, & Safety

Committed to Environment, Health, & Safety Committed to Environment, Health, & Safety Environment, Health, and Safety Management System and Policy of W. R. Grace & Co. November 8, 2018 The Grace Environment, Health, and Safety Management System,

More information

imarat consultants Company Profile

imarat consultants Company Profile imarat consultants Company Profile Sdn Bhd Registered in Malaysia, Reg No 729349-V South East Asian Office 44 Jalan Nuri 7/7 Kota Damansara 47810 Petaling Jaya Selangor Malaysia Tel/Fax: +603 6140 1477

More information

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce

More information

ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS

ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS Introduction The ECR Asia Pacific OSA working group conducted an online survey between July and September 2011 aimed at gaining insights

More information

For personal use only

For personal use only ASX ANNOUNCEMENT 22 NOVEMBER 2017 AGM ADDRESSES FROM THE CHAIRMAN & CEO 22 November 2017 Cann Group Limited (ASX: CAN) is pleased to provide the following addresses to be delivered by its Chairman Allan

More information

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf

More information

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020 BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...

More information

Environmental, Health and Safety

Environmental, Health and Safety Environmental, Health and Safety Codes of Practice The Environmental, Health and Safety (EHS) Codes of Practice set forth Zimmer EHS requirements for our business functions and facilities worldwide. In

More information

NET LEASE INVESTMENT OFFERING RITE AID PHARMACY

NET LEASE INVESTMENT OFFERING RITE AID PHARMACY RITE AID PHARMACY 11702 Lorain Avenue Cleveland, OH 44111 TABLE OF CONTENTS TABLE OF CONTENTS I. Executive Profile Executive Summary Investment Highlights Property Overview II. Location Overview Photographs

More information

Committed to Environment, Health and Safety

Committed to Environment, Health and Safety Committed to Environment, Health and Safety Environment, Health and Safety Management System and Policy of GCP Applied Technologies Inc. SEPTEMBER 1, 2017 The GCP Environment, Health, and Safety Management

More information

Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )

Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( ) Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast (2017-2022) By Region- North America, Europe, APAC and RoW By Country

More information

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,

More information

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports

More information

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord A/S GN GN Store Store Nord Nord Listed Listed company

More information

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List

More information

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Boehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider

Boehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider Boehringer Ingelheim Biopharmaceuticals in China Your Reliable Contract Manufacturing Solution Provider Dr. Bin Wang, Dr. Axel Schleyer Boehringer Ingelheim Biopharmaceuticals (China) Co., Ltd. Contact:

More information

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes 1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements

More information

For personal use only

For personal use only HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening

More information

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE 37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as

More information

Asia-Pacific Electrophysiology Market Outlook to 2020

Asia-Pacific Electrophysiology Market Outlook to 2020 Asia-Pacific Electrophysiology Market Outlook to 2020 Reference Code: GDMECR0114DB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 5 1.2 List of Figures...

More information

VITROLIFE AB (PUBL) Pareto Securities Health Care Conference

VITROLIFE AB (PUBL) Pareto Securities Health Care Conference VITROLIFE AB (PUBL) Pareto Securities Health Care Conference 2018-09-06 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION

More information

Value growth in Human Nutrition & Health

Value growth in Human Nutrition & Health Value growth in Human Nutrition & Health Rick Greubel President Human Nutrition & Health US Field Trip September 4, 2014 Safe harbor statement This presentation may contain forward-looking statements with

More information

Sarajevo Halal Fair (SHF) 2018

Sarajevo Halal Fair (SHF) 2018 Sarajevo Halal Fair (SHF) 2018 International halal industry fair with exhibition spaces (stands), presentations, business (B2B) meetings, expert and thematic panel discussions Date: September 27 to 29,

More information

LEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017

LEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017 LEERINK GLOBAL HEALTHCARE CONFERENCE Marino Garcia EVP, Chief Strategy Officer February 15, 2017 SAFE HARBOR STATEMENT This presentation and any statements made for and during any presentation or meeting

More information

概美科技. GuideMia Technologies, LLC Sept

概美科技. GuideMia Technologies, LLC Sept 概美科技 info@guidemia.com GuideMia Technologies, LLC Sept 2017 +1 714 391 2739 Offering worldwide dentists and dental labs image guided implant and digital orthodontics solutions and services that change

More information

Harm de Wildt MD TNI

Harm de Wildt MD TNI Harm de Wildt MD TNI Nutreco Capital Markets Day Derbyshire, UK 17 September 1 2013 Agenda 1 2 3 Market overview Animal Nutrition Europe Animal Nutrition strategic priorities Application Solution Centres

More information

BALCHEM CORPORATION. Q Investor Relations Presentation

BALCHEM CORPORATION. Q Investor Relations Presentation BALCHEM CORPORATION Q4 2017 Investor Relations Presentation Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life

More information

Development Bank of Southern Africa Amendment Bill [B ]

Development Bank of Southern Africa Amendment Bill [B ] Development Bank of Southern Africa Amendment Bill [B 2-2014] Briefing of Standing Committee on Finance National Assembly 8 July 2014 Presenters: Mr Lefentse Radikeledi Director: Asset and Liability Management

More information

Nestlé. In Society. Creating Shared Value Progress and Commitments Middle East

Nestlé. In Society. Creating Shared Value Progress and Commitments Middle East Nestlé In Society Creating Shared Value Progress and Commitments 2020 Middle East Nestlé s purpose is about enhancing quality of life and contributing to a healthier future. We have identified three areas

More information

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY

More information

CHILD ENDS HERE HOMELESSNESS. 3 Year Strategic Plan Inn from the Cold 3 Year Strategic Plan

CHILD ENDS HERE HOMELESSNESS. 3 Year Strategic Plan Inn from the Cold 3 Year Strategic Plan CHILD HOMELESSNESS ENDS HERE 3 Year Strategic Plan 2018-2021 a LET S HELP CHILDREN MORE Over the last 20 years, the Inn on our shelter, sanctuary and healing has grown from a grassroots organization to

More information

In- Vitro Fertilization (IVF) - Global Market Outlook ( )

In- Vitro Fertilization (IVF) - Global Market Outlook ( ) Report Information More information from: https://www.wiseguyreports.com/reports/456551-in-vitro-fertilization-ivf-global-market-outlook In- Vitro Fertilization (IVF) - Global Market Outlook (2015-2022)

More information

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update - All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months - Geneva, Switzerland

More information

COMPANY PROFILE. AL SHAMS Group

COMPANY PROFILE. AL SHAMS Group COMPANY PROFILE AL SHAMS Group Al Shams Pharma Scintific Bureau Shams Al-Ibdaa Drug Store Bilim Pharma Co. Al-Shams Drug Store Al-Murjan Drug Store Al-Aqsa Pharmacy & Cosmetic Al-Khadraa Pharmacy & Cosmetic

More information

Investor Relations 1Q 2017

Investor Relations 1Q 2017 Investor Relations 1Q 2017 History Leading Authentic Sports Brand Inspired by the Style, Elegance and Passion of our Italian Heritage Founded by FILA brothers in Biella, Italy Established FILA Korea FILA

More information

William Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations

William Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations William Demant Jefferies Healthcare Conf. Nov. 2017 Søren B. Andersson, VP Investor Relations Agenda General update Key take-aways from November Interim Statement Hearing Devices Outlook 2017 Q&A 2 General

More information

Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015

Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015 (Nasdaq:EVAR) Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015 Safe Harbor This presentation contains forward-looking statements as that term is defined in the Private Securities Litigation

More information

Annual Shareholders Meeting

Annual Shareholders Meeting Annual Shareholders Meeting February 8, 2018 Dow R. Wilson, President and Chief Executive Officer Forward-Looking Statements Except for historical information, this presentation contains forward-looking

More information

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Investor Day EEMA Region Lausanne, September 29, 2016 Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Agenda Overview and Key Results Vision and Strategic Pillars

More information

EU5 Bariatric Surgery Procedures Outlook to 2020

EU5 Bariatric Surgery Procedures Outlook to 2020 EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...

More information

Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3

More information

Global Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast ( )

Global Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast ( ) Global Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast (2017-2022) Analysis By Type - Fresh/Dried leaves, Stevia powder,

More information

Investor Presentation

Investor Presentation Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities

More information

Mexico Ostomy Drainage Bags Market Outlook to 2020

Mexico Ostomy Drainage Bags Market Outlook to 2020 Mexico Ostomy Drainage Bags Market Outlook to 2020 Reference Code: GDMECC0990DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...

More information

DISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER

DISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic

Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast

More information

HILLENBRAND INDUSTRIES INC

HILLENBRAND INDUSTRIES INC HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518

More information

Connecticut Family Stability Pay for Success Project FACT SHEET

Connecticut Family Stability Pay for Success Project FACT SHEET Connecticut Family Stability Pay for Success Project FACT SHEET Ensuring Family Stability is a priority for Governor Dannel Malloy, Department of Children and Families Commissioner Joette Katz, and the

More information

2018 Global Value-based Digital Dental Competitive Strategy Innovation and Leadership Award

2018 Global Value-based Digital Dental Competitive Strategy Innovation and Leadership Award 2018 Global Value-based Digital Dental Competitive Strategy Innovation and Leadership Award 2018 Contents Background and Company Performance Industry Challenges... 3 Strategy Innovation and Customer Impact...

More information

Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595

Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595 Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample

More information

MEMBERSHIP BOOKLET. Meeting Your Needs Through: Research, Sales Data, Staff Support, Networking

MEMBERSHIP BOOKLET. Meeting Your Needs Through: Research, Sales Data, Staff Support, Networking MEMBERSHIP BOOKLET Meeting Your Needs Through: Research, Sales Data, Staff Support, Networking MEMBERSHIP CATEGORIES Supplier Broker Association Allied Governmental NABCA operates on a fiscal year (July-June),

More information

PROACTIVE INVESTOR PRESENTATION

PROACTIVE INVESTOR PRESENTATION www.thcl.com.au ASX RELEASE (16 th May 2017) PROACTIVE INVESTOR PRESENTATION The Hydroponics Company Limited (ASX: THC) is pleased to advise that Dr Andrew Beehag, Chief Executive Officer of Canndeo Limited,

More information

Gavi s private sector engagement approach

Gavi s private sector engagement approach Gavi s 2016-2020 private sector engagement approach SCALING INNOVATION FOR IMPACT Gavi Board technical briefing session 21 June 2016 Geneva, Switzerland Reaching further, together www.gavi.org A HISTORY

More information

Report to the GAVI Alliance Board 7-8 July 2011

Report to the GAVI Alliance Board 7-8 July 2011 Report to the GAVI Alliance Board 7-8 July 2011 Subject: Report of: Authored by: GAVI Matching Fund for Immunisation David Ferreira, MD, Innovative Finance Paolo Sison, Director, Innovative Finance Agenda

More information

EPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets

EPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets EPIDEMIOLOGY Accurate, in-depth information for understanding and assessing targeted markets WHY ACCURATE MARKET FORECASTS Start with accurate understanding Epidemiology is the study of disease patterns

More information

Myriad Genetics Corporate Presentation 06/13/2018

Myriad Genetics Corporate Presentation 06/13/2018 Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today

More information

Silica Fume Market by Application (Building Construction, Marine Structure Construction, Oil & Gas Well Grouting, Nuclear Power Plant Construction,

Silica Fume Market by Application (Building Construction, Marine Structure Construction, Oil & Gas Well Grouting, Nuclear Power Plant Construction, Silica Fume Market by Application (Building Construction, Marine Structure Construction, Oil & Gas Well Grouting, Nuclear Power Plant Construction, Chemical Production Facilities Construction, by Geography

More information

Global In-Vitro-Fertilization Market: Trends and Opportunities ( )

Global In-Vitro-Fertilization Market: Trends and Opportunities ( ) Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019) Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019) BioPortfolio has been marketing business and market

More information

Investor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region

Investor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region Investor Day LA&C Region Lausanne, September 29, 2016 Jeanne Pollès President, Latin America & Canada Region Agenda Regional Overview and Performance Regional Strategies Key Markets Conclusion 2 LA&C Regional

More information

Upskill your staff for success

Upskill your staff for success Upskill your staff for success Empower your staff by upskilling them with an Active IQ elearning course. A skilled and motivated workforce can be the difference between a good and a great organisation.

More information

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014 1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include

More information

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential

More information

China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020

China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 Reference Code: GDMECC0079DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2

More information

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures

More information

Organ Transplantation Market Research Report- Global Forecast Till 2023

Organ Transplantation Market Research Report- Global Forecast Till 2023 Report Information More information from: https://www.marketresearchfuture.com/reports/915 Organ Transplantation Market Research Report- Global Forecast Till 2023 Report / Search Code: MRFR/HC/0410-HCRR

More information

VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar

VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar 2018-08-16 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION A Swedish

More information

Tamsulosin Hydrochloride 0.4 mg Capsule

Tamsulosin Hydrochloride 0.4 mg Capsule Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule

More information

Lakshy Management Consultant Pvt. Ltd.

Lakshy Management Consultant Pvt. Ltd. What is ISO 13485:2003? You can t buy trust. BUILD IT through ISO 13485. Demonstrate your ability to supply medical devices through Quality Management System for Medical Devices - ISO 13485 ISO 13485 is

More information

AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes

AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance Becoming Global Leaders In Diabetes 19th December 2013 Cautionary Statement Regarding Forward-Looking Statements In order,

More information

Radiation Safety. Safely Working with Radioactive Materials September 2017 Dubai, U.A.E.

Radiation Safety. Safely Working with Radioactive Materials September 2017 Dubai, U.A.E. Radiation Safety Safely Working with Radioactive Materials 10-14 September 2017 Dubai, U.A.E. 14-DEC-16 This course is Designed, Developed, and will be Delivered under ISO Quality Standards Radiation Safety

More information

POST SHOW REPORT. The Leading Dental Conference & Exhibition for Middle-East, Africa and South Asia markets.

POST SHOW REPORT. The Leading Dental Conference & Exhibition for Middle-East, Africa and South Asia markets. The Leading Dental Conference & Exhibition for Middle-East, Africa and South Asia markets. 22 Editions of Success to Reach Excellence. Organised by Strategic Partner POST SHOW REPORT 2018 Supported by

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.

More information